Photo Shoot: Visual Images Of Aging and Caregiving
August 23, 2023
No doubt you’ve heard the phrase “A picture’s worth 1,000 words.” When it comes to photographs documenting what it’s like to be in the throws of dementia (or a caregiver of a person living with dementia) or to be a long-married couple living your final days, the images captured by…
Grab Your Cape: It’s Time To Become A SuperAger!
August 9, 2023
There’s no doubt that our population is aging. And as a larger percentage of us get older, it’s important to understand how we can prolong our cognitive abilities and protect our brains from the ravages of dementia. After all, age is the major risk factor for Alzheimer’s, and projections are…
Detecting Dementia: How Can You Be Screened For Dementia?
July 26, 2023
There’s no doubt that we have entered an era when important opportunities will exist to delay or diminish the symptoms of dementia. As we’ve been covering in agebuzz, there is now a new drug (Leqembi) available to delay impairment and decline in patients with mild cognitive impairment or the early…
Driving To The Edge: When Is It Time To Hand Over The Keys?
July 26, 2023
For anyone who’s had to ask an older adult to give up driving, or who has made the decision for herself, you know how agonizing and distressing it can be to lay down the keys and say goodbye to what is likely a vital part of everyday life. This is…
Reducing Your Risk: More Research Insights Into Lowering Your Dementia Risk
July 19, 2023
If given the chance, most of us would welcome opportunities to strengthen our cognitive reserve and lower our risk for dementia. And if those opportunities coincided with enjoyable leisure activities, all the better. We already know that there are many lifestyle changes you can make to lower the likelihood of…
A Hope And A Prayer: Who Will Gain Access To The New FDA-Approved Alzheimer’s Treatment?
July 12, 2023
If you or a loved one suffers from mild cognitive impairment or have been diagnosed with early Alzheimer’s Disease, you’ve likely followed the news over the last few months about a new treatment awaiting FDA approval. Well, that FDA approval has arrived: Leqembi, a medication that targets the amyloid plaques…